Portfolio
Saros Therapeutics
Developing immunotherapies for the treatment of cancer and autoimmune diseases.(2026)
Skeletalis
Developing a novel small-molecule drug delivery system for local inhibition of disease at sites of bone degradation.(2026)
A2 Intelligence
A2 Intelligence is developing software using tensor networks to analyze complex systems to make decisions, with potential uses in machine diagnostics and physical cyber security.(2025)
Aquatonomy
Developing autonomous robotic inspection solutions of critical underwater infrastructure.(2025)
Arbor Halides
Arbor Halides is developing actinide molten salts for nuclear reactor development.(2025)
BlueShift Carbon
Developing technology for direct ocean capture (DOC) of CO2 gas from seawater.(2025)
Courage Therapeutics
Courage Therapeutics' two drug-development programs aim to address obesity and restrictive eating disorders, such as anorexia nervosa and cachexia, by targeting neural circuits in the brain known as the central melanocortin system.(2025)
Energy Equity Project
The Energy Equity Project aims to bolster a just transition to cleaner, more resilient energy systems and has developed the first standardized national framework for comprehensively measuring and advancing energy equity.(2025)
Fibarcode
Developing a system for photonic identification and tracking of textiles.(2025)
Fragmatics, LLC
Developing and extending the "Gold Standard" in Proteomic search engine optimization and related tools.(2025)
Genevi Technologies
Developing a medical device to treat stress urinary incontinence.(2025)
GripFusion
GripFusion is creating and selling an instrumented baseball that can measure and provide analytics on the pressure that is applied to baseball and its flight performance.(2025)
Humanica
Software to influence customer behavior by using attachment to peer groups.(2025)
Media Shield
Media Shield is commercializing software for real-time, AI-driven detection of deepfake audio and video with visual, transparent explainability.(2025)